So this is a growing threat that I think needs to be monitored closely. If GLP-1s do become prohibited, athletes could theoretically apply for a therapeutic use exemption (TUE), which allows them to take a drug if it is treating a legitimate medical condition, and does not meaningfully enhance their performance
First Generic GLP-1 for Obesity Gains FDA Approval The FDA approved Tevas generic Saxenda, the first GLP-1 drug for weight loss, expanding access to obesity treatment
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Retatrutide Peptide: Benefits, Uses, Side Effects, Dosage, and Research
Claims and Potential Benefits Proponents claim a wide array of benefits, believing that direct nutrient delivery bypasses gut absorption issues for more effective cell nourishment
Here are the main differences: Cost and convenience
Using Reverse Transcription-quantitative Polymerase Chain Reaction (RT-qPCR), Glp1r mRNA was detected in the OB of both RD and WD-fed mice and found to be significantly increased in the latter (Fig